New ETF Book by Larry Connors - Click here to read more
The Deerfield, Illinois-based company's sales for the month of June were $5.24 billion, an increase of 9.0%, compared to $4.80 billion in the year-ago period.
Comparable store front-end sales dropped 0.9% from last year's growth of 3.4%, hurt by softer sales of seasonal items compared with last year.
For the month of June, Walgreen's pharmacy sales advanced 11.0%, while comparable pharmacy sales increased 5.8%. Comparable pharmacy sales were negatively impacted by 4.4 percentage points due to generic drug introductions in the last 12 months.
Further, prescriptions filled at comparable stores rose 7.5% percent in June, including 1.5 percentage points, due to more patients filling 90-day prescriptions. Pharmacy sales accounted for 66.7% of total sales for the month.
The company noted that the calendar day shifts had a positive impact on the month, as pharmacy patients filled more prescriptions during the week than on weekends. In 2009, June had one more weekday compared to June in the previous year. Calendar shifts positively impacted total comparable store sales by 1.5 percentage points, comparable pharmacy sales by 2.3 percentage points and prescriptions filled in comparable stores by 2.2 percentage points.
Year-to-date calendar sales were $31.8 billion, up 7.1% from the previous year's sales of $29.7 billion. Fiscal 2009 year-to-date sales for 10-month totaled $52.9 billion, an increase of 7.4%, compared to $49.2 billion reported a year earlier. Comparable store sales for the fiscal year-to-date increased 2.1%.
For the preceding month of May, Walgreen generated total sales of $5.37 billion, versus $5.06 billion in the same period of the previous year. Comparable store front-end sales increased 0.2% in May, compared to a growth of 6.0% in the prior year.
During June, Walgreen, which also operates worksite health centers, home care facilities, opened 46 stores, including five re-locations, and acquired four stores. As at June 30, the company operated 7,407 locations in all 50 states, the District of Columbia, Puerto Rico and Guam.
Among Walgreen's peers, Rite Aid Corp. (RAD | Quote | Chart | News | PowerRating) reported June same-store sales decline of 0.6%. Same-store sales, excluding the acquired Brooks Eckerd stores, were flat compared to the prior-year period, with front-end same-store sales decreasing 4.4% and pharmacy same-store sales increasing 2.6%.
Rite Aid's June front-end same-store sales descended 4.5%, while pharmacy same-store sales, which included an approximate 484 basis points negative impact from new generic introductions, rose 1.4%.
Walgreen shares, which have been trading between $21.28 and $37.85 in the past 52 weeks on NYSE, closed Wednesday's trading session at $29.34, down 6 cents or 0.20%.
For comments and feedback: contact editorial@rttnews.com Copyright(c) 2009 RTTNews.com, Inc. All Rights Reserved
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
